Clinical Trials in Denver

Showing 17481-17500 of 18,161 trials

A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis

NCT00006280

This study's primary goals are to test the safety and effectiveness of Tobramycin for Inhalation (TOBIr) in cystic fibrosis (CF) patients who are between 6 months and 6 years of age. This drug is an antibiotic that is inhaled into the lungs by the patient. It has already been studied and approved by the FDA for treatment of CF patients 6 years and older. Lung fluid will be examined for bacteria before and after the 28-day treatment. The amount of bacteria before and after treatment will be compared. This will indicate whether the antibiotic was effective in killing bacteria in the lungs. Once treatment begins, patients will be monitored every 2 weeks throughout the study (5 exams in 56 days). Half of the patients will receive TOBIr, half will receive a placebo (a substance that looks like TOBIr but contains no medication).

Cystic Fibrosis

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)98 participantsStarted Feb 2000

Palo Alto, California, United States • Denver, Colorado, United States • Baltimore, Maryland, United States +6 more locations

WITHDRAWNPhase 2< 1 mile

Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension

NCT00453414

The purpose of this study is to evaluate the safety and effectiveness of iloprost for PAH in children who are between the ages of 3 and 18 years old.

Pulmonary Arterial Hypertension

ActelionStarted Jul 2006

Denver, Colorado, United States • New York, New York, United States

A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis

Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension

Find Trials by Condition in Denver

Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy

Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia

Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass

Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma

Randomized Study of Human-Milk Based Nutrition Versus Formula in Premature Infants

Pilot Study of the Efficacy and Safety of Lidoderm Patch in the Treatment of Low Back Pain

Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism

Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Extended Management and Measurement of Autism

A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer

Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background

Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis

Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies

Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer

Study of XL999 in Patients With Multiple Myeloma

Preimplantation Genetic Diagnosis for the Indication of Advanced Reproductive Age

Study of XL999 in Patients With Previously Treated Ovarian Cancer

A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy